Filter
245
Filtered Results: 245
Text search:
non-inferiority
Featured
Recommendations
22
New Publications
38
Language
Document type
No document type
106
Studies & Reports
48
Guidelines
48
Manuals
15
Strategic & Response Plan
13
Fact sheets
6
Situation Updates
4
Training Material
3
Resource Platforms
1
Infographics
1
Countries / Regions
Global
7
India
6
Ukraine
6
Tanzania
5
Kenya
4
South Africa
4
Latin America and the Carribbean
4
Ethiopia
3
Philippines
3
South Sudan
3
Zambia
3
Malawi
3
Brazil
3
Myanmar / Burma
3
Congo, Democratic Republic of
2
Zimbabwe
2
Western and Central Europe
2
Africa
2
Burkina Faso
1
Sierra Leone
1
Liberia
1
Nigeria
1
Ghana
1
Uganda
1
Afghanistan
1
Germany
1
Thailand
1
Rwanda
1
Indonesia
1
Bangladesh
1
Papua New Guinea
1
Central African Republic
1
Angola
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Italy
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Russia
1
Mauritius
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
55
Clinical Guidelines
53
Public Health
15
Women & Child Health
14
Pharmacy & Technologies
5
Key Resources
4
Capacity Building
3
Toolboxes
HIV
35
COVID-19
30
TB
27
NTDs
18
Mental Health
13
AMR
8
NCDs
7
Rapid Response
6
Caregiver
6
Disability
5
Cholera
5
Conflict
5
Planetary Health
5
Refugee
4
Pharmacy
4
Polio
3
Ebola
2
Social Ethics
2
Global Health Education
1
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
Updated Guidelines
Este documento presenta modelos de algoritmos que permiten investigar por métodos bacteriológicos a los pacientes para el diagnóstico de tuberculosis (TB), TB asociada al Virus de Inmunodeficiencia Humana (TB-HIV) y TB drogorresistente (TBDR).
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
Meeting the rehabilitation needs of people affected by leprosy and promoting quality of life.
